Pharma IQ releases new infographic summary of results from industry survey

Pharma IQ is pleased to announce the release of a brand new infographic summary of the results from an industry survey conducted earlier this year.

Nearly a third of all respondents stated that CROs would be an area of active investment in the next 6 months. 50% of respondents will be running 6 or more clinical trials in the BRIC region. The infographic, created in association with the Clinical Trial Supply USA Summit explores the latest trends, challenges and opportunities in clinical trial supply and is available to access free of charge. Download the infographic online at https://www.iqpc.com/.

The Clinical Trial Supply USA Summit, taking place in Boston in September, is a unique event focusing on how to achieve flexibility, cut costs and streamline your organization's clinical supply. The Summit also brings the latest in European regulatory insight to the states.

Industry experts speaking at the event include;

Buz Hillman, Associate Director, Clinical Supply Systems, Johnson and Johnson; Mary Foster, Chair, Packaging and Storage Expert Committee, United States Pharmacopeia; Riekert Bruinick, Senior GMP/GDP Inspector, Dutch Healthcare Inspectorate; John Griffen, Global Clinical Supplies, ENVIVO Pharma; Lindsay Pinnick, Global Supply Coordinator, UCB Pharma; Ronald Wong, Clinical Pharmacist, Genzyme; Brian Venturi, Project Manager, Merck; Justin Doel, Head, Global Clinical Supplies, Novartis Vaccines and Diagnostics, Inc.; Doug Meyer, Senior Manager - Process Optimization, Clinical Supply, Biogen Idec; David Sherris, President CEO, PALOMA pharma to name a few.

For more information about speakers and the agenda or how to get involved, please visit: https://www.iqpc.com/ or email us at [email protected].